DETOXIFICATION OF PLASMA CONTAINING LIPOPOLYSACCHARIDE BY ADSORPTION

被引:33
作者
BYSANI, GK
SHENEP, JL
HILDNER, WK
STIDHAM, GL
ROBERSON, PK
机构
[1] ST JUDE CHILDRENS RES HOSP, DEPT INFECT DIS, DIV BIOSTAT, MEMPHIS, TN 38101 USA
[2] LEBONHEUR CHILDRENS HOSP & MED CTR, MEMPHIS, TN USA
[3] UNIV TENNESSEE, CTR HLTH SCI, DEPT PEDIAT, MEMPHIS, TN 38163 USA
关键词
D O I
10.1097/00003246-199001000-00015
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
We compared the ability of 13 materials, all with known affinity for lipopolysaccharide (LPS), to remove LPS from water, pooled normal human plasma, and plasma from a patient with Gram-negative bacterial sepsis. Escherichia coli O111:B4 LPS was added to water and pooled normal human plasma to a concentration of 200 ng/ml and aliquots were adsorbed in parallel with each of the materials. Plasma containing 25 ng/ml of LPS was obtained by plasmapheresis from a patient with fatal Klebsiella pneumoniae sepsis and was similarly absorbed. Ethanolamine bound to Sepharose 4B® served as a control adsorbent. LPS was most readily removed from water and least readily removed from plasma obtained from the patient with sepsis. Nontheless, some materials removed substantial quantities of LPS from the patient's plasma. Upon ip injection of control-adsorbed patient's plasma into LPS-sensitized mice, death occurred in 13 of 13 mice within 12 h. In contrast, when this plasma was first adsorbed with activated charcoal, Kaopectate®, or polymyxin B bound to Sepharose 4B, death occurred 12 h after challenge in 0/13, 0/13, adn 2/13 mice, respectively (p < .0001 by actuarial life table analysis of survival distributions). Thus, plasma that contains bacterial toxins produced during Gram-negative bacterial sepsis can be detoxified by adsorption.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 18 条
[1]
ENDOTOXIN REMOVAL FROM LARGE-VOLUME PARENTERALS BY VARIOUS ADSORBENTS [J].
BAGGERMAN, C ;
LOOS, JA ;
JUNGINGER, HE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 27 (01) :17-27
[2]
BENDE S, 1986, CIRC SHOCK, V19, P239
[3]
EVALUATION OF ABSORPTION WITH LIMULUS-AMEBOCYTE LYSATE TO REMOVE CONTAMINATING ENDOTOXIN FROM INTERFERON AND LYMPHOKINE PREPARATIONS [J].
BIONDI, A ;
LANDOLFO, S ;
FUMAROLA, D ;
POLENTARUTTI, N ;
INTRONA, M ;
MANTOVANI, A .
JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 66 (01) :103-112
[4]
PROTECTION FROM ENDOTOXEMIA - A RAT MODEL OF PLASMAPHERESIS AND SPECIFIC ADSORPTION WITH POLYMYXIN-B [J].
COHEN, J ;
ASLAM, M ;
PUSEY, CD ;
RYAN, CJ .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (04) :690-695
[5]
INACTIVATION OF ENDOTOXIN BY POLYMYXIN-B [J].
COOPERSTOCK, MS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1974, 6 (04) :422-425
[6]
DITTER B, 1983, GASTROENTEROLOGY, V84, P1547
[8]
ENDOTOXINS AND DISEASE MECHANISMS [J].
MORRISON, DC ;
RYAN, JL .
ANNUAL REVIEW OF MEDICINE, 1987, 38 :417-432
[9]
NOLAN JP, 1975, GASTROENTEROLOGY, V69, P1346
[10]
EFFECT OF CHOLESTYRAMINE ON ENDOTOXIN TOXICITY AND ABSORPTION [J].
NOLAN, JP ;
VILAYATA.M .
AMERICAN JOURNAL OF DIGESTIVE DISEASES, 1972, 17 (02) :161-&